The Cigna Group (NYSE:CI) Given Average Recommendation of “Buy” by Analysts

The Cigna Group (NYSE:CI) has been assigned an average recommendation of “Buy” from the fifteen brokerages that are covering the firm, MarketBeat.com reports. One investment analyst has rated the stock with a hold recommendation, thirteen have assigned a buy recommendation and one has issued a strong buy recommendation on the company. The average 1-year price target among brokerages that have issued ratings on the stock in the last year is $395.93.

Several brokerages have issued reports on CI. Truist Financial lowered their target price on The Cigna Group from $420.00 to $390.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. Piper Sandler reaffirmed an “overweight” rating and set a $394.00 price objective (up from $392.00) on shares of The Cigna Group in a report on Tuesday, November 5th. Deutsche Bank Aktiengesellschaft reduced their target price on shares of The Cigna Group from $398.00 to $394.00 and set a “buy” rating for the company in a research note on Monday, November 4th. StockNews.com lowered shares of The Cigna Group from a “strong-buy” rating to a “buy” rating in a research report on Monday, November 4th. Finally, Stephens reaffirmed an “overweight” rating and issued a $410.00 price objective on shares of The Cigna Group in a report on Friday, November 1st.

The Cigna Group Stock Up 1.1 %

CI stock opened at $284.16 on Monday. The Cigna Group has a 1-year low of $262.03 and a 1-year high of $370.83. The stock has a market cap of $79.04 billion, a P/E ratio of 26.81, a P/E/G ratio of 0.75 and a beta of 0.54. The stock’s fifty day simple moving average is $302.08 and its two-hundred day simple moving average is $327.07. The company has a current ratio of 0.72, a quick ratio of 0.72 and a debt-to-equity ratio of 0.71.

The Cigna Group (NYSE:CI) last posted its quarterly earnings results on Thursday, October 31st. The health services provider reported $7.51 earnings per share for the quarter, beating the consensus estimate of $7.22 by $0.29. The company had revenue of $63.70 billion during the quarter, compared to analyst estimates of $59.58 billion. The Cigna Group had a net margin of 1.31% and a return on equity of 18.42%. The firm’s revenue for the quarter was up 29.8% on a year-over-year basis. During the same quarter in the prior year, the business earned $6.77 earnings per share. Analysts expect that The Cigna Group will post 28.5 EPS for the current year.

The Cigna Group Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Thursday, December 19th. Shareholders of record on Wednesday, December 4th were given a dividend of $1.40 per share. The ex-dividend date of this dividend was Wednesday, December 4th. This represents a $5.60 annualized dividend and a yield of 1.97%. The Cigna Group’s payout ratio is presently 52.83%.

Institutional Trading of The Cigna Group

Institutional investors and hedge funds have recently made changes to their positions in the stock. Ulland Investment Advisors LLC increased its stake in The Cigna Group by 2,500.0% in the third quarter. Ulland Investment Advisors LLC now owns 104 shares of the health services provider’s stock valued at $36,000 after acquiring an additional 100 shares during the last quarter. Prospera Private Wealth LLC purchased a new position in shares of The Cigna Group in the 3rd quarter worth about $37,000. ORG Wealth Partners LLC bought a new position in shares of The Cigna Group during the 4th quarter valued at about $34,000. Harbor Capital Advisors Inc. purchased a new position in shares of The Cigna Group during the 3rd quarter valued at about $45,000. Finally, Intact Investment Management Inc. bought a new stake in The Cigna Group in the 3rd quarter worth approximately $69,000. Hedge funds and other institutional investors own 86.99% of the company’s stock.

The Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.